title: Tivozanib: is total VEGFR inhibition the way to success in terms of tolerability and efficacy in advanced kidney cancer?
authors.affiliation: 1 Saint-André Hospital, University Hospital, Bordeaux, France ; 2 Université Bordeaux 2, Victor Segalen, Bordeaux, France.
authors.forename: Marine
authors.initials: M
authors.lastname: Gross-Goupil
authors.affiliation: 1 Saint-André Hospital, University Hospital, Bordeaux, France ; 2 Université Bordeaux 2, Victor Segalen, Bordeaux, France.
authors.forename: Alain
authors.initials: A
authors.lastname: Ravaud
references.citation: J Natl Cancer Inst. 2011 May 4;103(9):763-73
references.pmid: 21527770
references.citation: J Clin Oncol. 2012 May 10;30(14):1678-85
references.pmid: 22493422
references.citation: J Clin Oncol. 2013 Oct 20;31(30):3791-9
references.pmid: 24019545